Your browser doesn't support javascript.
loading
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFß and PD-L1, in Patients with Esophageal Squamous Cell Carcinoma: Results from a Phase 1 Cohort in Asia.
Lin, Chia-Chi; Doi, Toshihiko; Muro, Kei; Hou, Ming-Mo; Esaki, Taito; Hara, Hiroki; Chung, Hyun Cheol; Helwig, Christoph; Dussault, Isabelle; Osada, Motonobu; Kondo, Shunsuke.
Affiliation
  • Lin CC; National Taiwan University Hospital, Taipei, Taiwan.
  • Doi T; National Cancer Center Hospital East, Kashiwa, Japan.
  • Muro K; Aichi Cancer Center Hospital, Nagoya, Japan.
  • Hou MM; Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.
  • Esaki T; National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Hara H; Saitama Cancer Center, Saitama, Japan.
  • Chung HC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
  • Helwig C; Merck KGaA, Darmstadt, Germany.
  • Dussault I; EMD Serono Research and Development Institute, Inc., Billerica, MA, USA.
  • Osada M; An Affiliate of Merck KGaA, Darmstadt, Germany.
  • Kondo S; Merck Biopharma Co., Ltd., Tokyo, Japan.
Target Oncol ; 16(4): 447-459, 2021 07.
Article in En | MEDLINE | ID: mdl-33840050

Full text: 1 Database: MEDLINE Main subject: Esophageal Neoplasms / Transforming Growth Factor beta / B7-H1 Antigen / Esophageal Squamous Cell Carcinoma Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Esophageal Neoplasms / Transforming Growth Factor beta / B7-H1 Antigen / Esophageal Squamous Cell Carcinoma Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Year: 2021 Type: Article